New York City-based Hospital for Special Surgery has received President’s Choice Awards from the American Society of Regional Anesthesia and Pain Medicine, recognizing two of its pain control approach studies.
The first study sought to determine the prevalence of cannabidiol use in patients scheduled to undergo sports medicine procedures. While opioid use carries risk of addiction, promising alternatives in pain management are available through CBD, according to a May 2 news release sent to Becker’s.
Researchers sent surveys to 470 patients between September and December 2024, with 39% of patients reporting having tried CBD. One-third reported using CBD on an as-needed basis, primarily for pain or to help them sleep.
“At HSS, ongoing data collection and analysis will further elucidate the perceived efficacy of cannabidiol and the potential for changes to prescription medication use with the incorporation of CBD,” Alexandra Sideris, PhD, director of the pain prevention research center at HSS, said in the release.
The second study determined that patients who had robotic-assisted total hip replacement surgery needed less opioid medication during hospitalization compared to patients who had computer-assisted or manual replacements.
Researchers reviewed almost 100,000 hip replacement cases and noted lower rates of opioid consumption among robotic-assisted surgery patients. They noted that the cause may be due to robotic-assisted surgeries contributing to less acute inflammation and less pain immediately after the procedure.
